About Atsena
Clinical and Scientific Advisory Boards
Clinical and Scientific Advisory Boards
José-Alain Sahel
José-Alain Sahel, MD
Distinguished Professor and Chairman, Department of Ophthalmology, University of Pittsburgh School of Medicine
Professor of Ophthalmology, Sorbonne Université, Paris, France

José-Alain Sahel, MD, is Distinguished Professor Chairman of the Department of Ophthalmology at the University of Pittsburgh School of Medicine and the Eye & Ear Foundation Endowed Chair, and Director of the UPMC Eye Center. He is an Exceptional Class Professor of Ophthalmology at the Medical School of Sorbonne Université and Founder Director of The Vision Institute (Sorbonne/Inserm/CNRS), Paris, France.

He is a clinician-scientist conducting research on vision restoration in retinal degenerative diseases, focusing on cellular and molecular mechanisms underlying retinal degeneration, development of treatments for currently untreatable retinal diseases by pharmacological treatments, gene therapy, stem-cell therapy, and retinal prosthesis. He has co-authored over 600 peer-reviewed articles and holds more than 40 patents. He received several awards, e.g. the Foundation Fighting Blindness Trustee Award, the Alcon Research Institute Award for Excellence in Vision Research, the Llura Liggett Gund Award from Foundation Fighting Blindness. He was elected to the Academia Ophthalmologica Internationalis, the Academy of Sciences-Institut de France, the German National Academy of Sciences Leopoldina, the National Academy of Technologies of France and the Association of American Physicians. He holds an Honoris Causa doctorate from the University of Geneva. Dr. Sahel was a co-founder of Fovea Pharmaceuticals, StreetLab, GenSight Biologics, Pixium Vision, Sparing Vision. He is a member of several Editorial Boards, including Science Translational Medicine.

accessibility optionsAccessibility
Text Size
A
A